| iPSC-Derived Astrocytes | |
|---|---|
| Lineage | Stem Cell > iPSC > Astrocyte |
| Markers | GFAP, S100β, ALDH1L1, AQP4, EAAT1, EAAT2 |
| Brain Regions | In Vitro |
| Disease Relevance | Alzheimer's Disease, Parkinson's Disease, ALS, Astrocytosis |
| Protocol | Directed Differentiation (30-90 days) |
Ipsc Derived Astrocytes is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
iPSC-Derived Astrocytes are specialized glial cells generated from induced pluripotent stem cells (iPSCs) through directed differentiation protocols that recapitulate astrogliogenesis during central nervous system development.1 These cells express characteristic astrocytic markers including GFAP (glial fibrillary acidic protein), S100β, ALDH1L1, and the water channel AQP4, defining their identity as authentic astrocytes.2
iPSC-derived astrocytes provide physiologically relevant in vitro models for studying neurodevelopment, neuroinflammation, and neurodegenerative diseases.3 These cells are particularly valuable for modeling Alzheimer's disease, Parkinson's disease, and ALS, where astrocyte dysfunction plays a critical role in disease pathogenesis.4
The generation of astrocytes from iPSCs typically follows a directed differentiation approach:
| Marker | Type | Function |
|---|---|---|
| GFAP | Intermediate Filament | Astrocyte identity, reactivity |
| S100β | Calcium-binding Protein | Astrocyte maturation |
| ALDH1L1 | Enzyme | Folate metabolism |
| AQP4 | Water Channel | Water homeostasis |
| EAAT1 (GLAST) | Transporter | Glutamate uptake |
| EAAT2 (GLT1) | Transporter | Glutamate uptake |
| Connexin 43 | Gap Junction | Astrocyte coupling |
iPSC-derived astrocytes from AD patients exhibit:
| Differentiation Method | Maturation Time | Marker Expression | Function |
|---|---|---|---|
| Spontaneous differentiation | 60-90 days | Variable | Research |
| CNTF/BMP patterning | 30-60 days | Robust | Disease modeling |
| Defined medium | 40-70 days | Moderate | Standardization |
The study of Ipsc Derived Astrocytes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.